Item 2.02 Results of Operations and Financial Condition.
On May 14, 2021, PLx Pharma Inc. (the "Company") issued a press release
announcing its financial results for its first quarter ended March 31, 2021. The
Company's press release is attached hereto as Exhibit 99.1 and the information
set forth therein is incorporated herein by reference and constitutes a part of
The information furnished by the Company pursuant to this Item 2.02, including
Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise
subject to the liability of that section, and shall not be deemed to be
incorporated by reference into any Company filing under the Securities Act of
1933, as amended, or the Exchange Act, regardless of any general incorporation
language in such filing.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description
99.1 Press Release, dated May 14, 2021.
© Edgar Online, source Glimpses